Journal
JOURNAL OF PROTEOME RESEARCH
Volume 16, Issue 1, Pages 228-237Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jproteome.6b00496
Keywords
immunology; mass spectrometry; glycopeptide analysis; MHC class II
Categories
Funding
- Melanoma Research Alliance
- National Institutes of Health [AI033993]
- USPHS [R01 A120963, CA134060]
- Sidney Kimmel Scholar award
Ask authors/readers for more resources
The MHC class II (MHCII) processing pathway presents peptides derived from exogenous or membrane-bound proteins to CD4+ T cells. Several studies have shown that glycopeptides are necessary to modulate CD4+ T cell recognition, though glycopeptide structures in these cases are generally unknown. Here, we present a total of 93 glycopeptides from three melanoma cell lines and one matched EBV-transformed line with most found only in the melanoma cell lines. The glycosylation we detected was diverse and comprised 17 different glycoforms. We then used molecular modeling to demonstrate that complex glycopeptides are capable of binding the MHC and may interact with complementarity determining regions. Finally, we present the first evidence of disulfide-bonded peptides presented by MI-ICIL This is the first large scale study to sequence glyco- and disulfide bonded MHCII peptides from the surface of cancer cells and could represent a novel avenue of tumor activation and/or immunoevasion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available